Two Sigma Advisers’s CRH Medical Corporation CRHM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-474,000
Closed -$1.87M 2819
2021
Q1
$1.87M Buy
+474,000
New +$1.53M 0.01% 1296
2020
Q3
Sell
-14,600
Closed -$30K 2722
2020
Q2
$30K Sell
14,600
-3,300
-18% -$6.67K ﹤0.01% 2448
2020
Q1
$24K Hold
17,900
﹤0.01% 2409
2019
Q4
$62K Sell
17,900
-8,500
-32% -$26.8K ﹤0.01% 2283
2019
Q3
$81K Sell
26,400
-7,900
-23% -$23.4K ﹤0.01% 2127
2019
Q2
$104K Sell
34,300
-119,800
-78% -$343K ﹤0.01% 2211
2019
Q1
$410K Sell
154,100
-66,200
-30% -$204K ﹤0.01% 1869
2018
Q4
$675K Buy
220,300
+24,700
+13% +$81.4K ﹤0.01% 1654
2018
Q3
$778K Buy
+195,600
New +$721K ﹤0.01% 1610
2017
Q3
Sell
-167,300
Closed -$952K 2406
2017
Q2
$952K Buy
167,300
+69,800
+72% +$453K ﹤0.01% 1540
2017
Q1
$798K Sell
97,500
-12,900
-12% -$89.2K ﹤0.01% 1690
2016
Q4
$589K Buy
+110,400
New +$560K ﹤0.01% 1783
2016
Q1
Sell
-36,800
Closed -$109K 2179
2015
Q4
$109K Sell
36,800
-21,866
-37% -$60.6K ﹤0.01% 1763
2015
Q3
$188K Buy
+58,666
New +$212K ﹤0.01% 1654

Two Sigma Advisers's CRHM Position: Q2 2021 in Review

Two Sigma Advisers sold out of CRH Medical Corporation (CRHM) in Q2 2021, closing a stake of 474,000 shares — an estimated $1.87M sold.

Two Sigma Advisers first reported a position in CRHM in Q3 2015 and held it in 14 quarters. The position peaked at $1.87M in Q1 2021. 1 fund tracked by Wall St. Rank holds CRHM as of Q2 2021.

  • Two Sigma Advisers reported no remaining CRH Medical Corporation position as of Q2 2021 after selling out during the quarter.
  • Two Sigma Advisers sold 474,000 CRH Medical Corporation shares in Q2 2021, an estimated $1.87M.
  • Two Sigma Advisers first reported a position in CRH Medical Corporation in Q3 2015 and held it in 14 quarters.
  • Two Sigma Advisers's CRH Medical Corporation position peaked at $1.87M in Q1 2021.
  • 1 fund tracked by Wall St. Rank held CRH Medical Corporation as of Q2 2021.

Based on Two Sigma Advisers's 13F filing for Q2 2021, filed 16 Aug 2021.